We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go: TBC investment: £127,001
Rype addresses the dilemma of choosing between expensive or low-quality office furniture that contributes to carbon emissions and waste. By remanufacturing high-quality used office furniture, Rype offers cost-effective solutions with 80% lower carbon emissions and waste, while creating local jobs. Their mission is to significantly reduce office carbon emissions and costs through sustainable, circular economy practices, including exclusive furniture ranges made from waste materials. Rype's comprehensive services encompass furniture sourcing, remanufacturing, and employing marginalized individuals, contributing to a more environmentally friendly and socially responsible approach to office furnishings.
days to go: Extended investment: Withheld
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go: Extended investment: Withheld
GoPower offers comprehensive portable solar energy solutions, designed to save you money and reduce your environmental impact. Their user-friendly solar panels eliminate the need for complex installations, allowing easy setup anywhere. Their portable solar power stations, providing up to 1000w/1280WH at 240v, are perfect for various applications such as home offices, garden rooms, boats, events, and more. With multiple output sockets and versatile charging options including solar panels and mains electricity, GoPower provides a greener and cost-effective energy alternative.
days to go: Extended investment: £10,000
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go: Extended investment: £295,000
Plerith works with high growth start-ups and scaling companies to plan for and deliver growth. The company asserts that it helps companies promote their business to potential funders, through its network of angel and venture capital investors depending on the stage and sector of the said business. Plerith is partnering with Newable and Bristol Private Equity Club to deliver the fund in the South West London (SWL) area and identify and invest in the most exciting high growth companies in the region. Plerith argues that its deep knowledge of fundraising, sales, strategy, finance and technology would help SWL businesses flourish. Plerith aims to provide investors access to the highest quality local companies in the SWL region.
days to go: Stretch investment: Withheld
rais is a virtual customer data analyst designed to stop socially unintelligent marketing and save the customers heaps of time in the process. The clever software platform of rais imports customer data from first-party sources to automatically deduplicate records. The monthly recurring revenue of rais is above £20K, and it has worked with more than 50 brands. Its software is trusted by many businesses like Original Cottages, Heartier, and Warner Edwards. Analyses engines kick in enriched customer meta-data that syncs with marketing channels to stop, start, or adjust marketing messages automatically based on individual customer circumstances. rais' vision is to build a virtual data-analyst for SMEs who do not have the time and ability to really leverage their customer data assets.
days to go: Expired investment: £150,000
iBan Wallet has created an app which allows users to be in control of their finances, connecting them to the people involved in any transaction. They will create a space for investors and also for borrowers, allowing the borrowers to be in control of the amount of interest they pay. 
days to go: Expired investment: £111,648
Repair Village is a phone repair comparison website, which enables the customer to find trusted local repair shops and compare which is the nearest, cheapest or offers the longest warranty.
days to go: Expired investment: £21,060
Growthdeck is seeking up to £1 million in funding to capitalize on a positive economic environment and a promising pipeline of opportunities. Despite challenging economic conditions in recent years, the company has outperformed the industry by achieving year-on-year growth in equity fundraising and improving deal flow and quality. With enhanced efficiency and reduced costs, Growthdeck is well-positioned to resume its rapid growth trajectory. Investor interest has rebounded, and the company's increased understanding of investor preferences allows them to identify more suitable deals. Having obtained FCA authorization as a Fund Manager, Growthdeck plans to launch Funds in 2023. The company's objective is to build a business worth over £50 million by 2027, catering to high and ultra-high net worth investors by arranging investments in private companies, backed by a loyal member base. 
days to go: Expired investment: Withheld
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph